A scientific study published in 2015 took another pharmacological look at the intensive therapeutic potential of the ancient African plant, iboga, by isolating it to its main hallucinogenic chemical component, noribogaine. Taking a look at the how the administration of noribogaine affected the self-administration that lab rats developed with nicoctine, leading to a clinical physical dependency.
Ibogaine is already renown across the globe for being the most extensive psychedelic for substance-abuse rehabilitation that pharmacology has yet to come across, definitively showing to break things like physical dependencies to heroin, alcohol, and other less destructive substance like nicotine, or surely even caffeine.
What science is now on the verge of showing is that iboga is a habit disrupter–it jostles brain mechanisms and gives a new and altered state of reassessment. This is the template for all psychedelic drugs, but iboga seems as well to be a disrupter of these habits physically, which is quite a novel finding for addiction rehabilitation. Yet, for some reason, this drug as well is still under felony classification in the US.
For those interested, here is the full published study on the effects that iboga has on physical dependency disruption, with nicotine specifically. Most published research studies usually only give the Abstract of the study, and all the references and bibliography for free, but this study is actually published in its entirely, with every single detail of it given for reading comprehension. Enjoy!